Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$302.2m reported value -1.5% vs Q1 2025
103positions
45.0%in top 10
24 new 14 added 28 reduced 37 sold out vs Q1 2025

Options: 23 call positions ($139.7m notional), 7 put positions ($78.7m notional) – listed below, not included above.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 464,488 $22.6m7.49% 7.49% AddedShares held: Q3 2024 0, Q4 2024 53.9k, Q1 2025 248.9k, Q2 2025 464.5k +215.5k +215,548 86.6%
2 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 56,594 $18.5m6.11% 6.11% AddedShares held: Q3 2024 8.7k, Q4 2024 0, Q1 2025 31.6k, Q2 2025 56.6k +25.0k +25,000 79.1%
3 INSMED INC COM PAR $.01 INSM INSM 163,751 $16.5m5.45% 5.45% AddedShares held: Q3 2024 154.8k, Q4 2024 119.8k, Q1 2025 84.8k, Q2 2025 163.8k +79.0k +78,951 93.1%
4 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 146,831 $13.9m4.59% 4.59% AddedShares held: Q3 2024 0, Q4 2024 80.0k, Q1 2025 130.0k, Q2 2025 146.8k +16.8k +16,831 12.9%
5 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 433,431 $12.5m4.12% 4.12% ReducedShares held: Q3 2024 426.9k, Q4 2024 516.4k, Q1 2025 523.4k, Q2 2025 433.4k -90.0k -90,000 -17.2%
6 AKERO THERAPEUTICS INC COM AKRO AKRO 220,000 $11.7m3.88% 3.88% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 245.0k, Q2 2025 220.0k -25.0k -25,000 -10.2%
7 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 276,950 $11.6m3.85% 3.85% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 145.5k, Q2 2025 276.9k +131.4k +131,448 90.3%
8 APOGEE THERAPEUTICS INC COM COM 232,047 $10.1m3.33% 3.33% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 232.0k
9 VAXCYTE INC COM PCVX PCVX 305,000 $9.9m3.28% 3.28% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 200.0k, Q2 2025 305.0k +105.0k +105,000 52.5%
10 ALPHA COGNITION INC COM NEW ACOG ACOG 917,867 $8.6m2.83% 2.83% ReducedShares held: Q3 2024 0, Q4 2024 755.9k, Q1 2025 967.9k, Q2 2025 917.9k -50.0k -50,000 -5.2%
11 TARSUS PHARMACEUTICALS INC COM TARS TARS 196,536 $8.0m2.63% 2.63% ReducedShares held: Q3 2024 1.0m, Q4 2024 607.7k, Q1 2025 485.0k, Q2 2025 196.5k -288.5k -288,485 -59.5%
12 CYTOKINETICS INC COM NEW CYTK CYTK 233,464 $7.7m2.55% 2.55% AddedShares held: Q3 2024 170.1k, Q4 2024 150.0k, Q1 2025 150.0k, Q2 2025 233.5k +83.5k +83,482 55.7%
13 SAREPTA THERAPEUTICS INC COM SRPT SRPT 449,087 $7.7m2.54% 2.54% AddedShares held: Q3 2024 54.2k, Q4 2024 34.1k, Q1 2025 169.1k, Q2 2025 449.1k +280.0k +280,000 165.6%
14 TG THERAPEUTICS INC COM TGTX TGTX 209,938 $7.6m2.50% 2.50% ReducedShares held: Q3 2024 0, Q4 2024 291.2k, Q1 2025 210.1k, Q2 2025 209.9k -127 -127 -0.1%
15 COGENT BIOSCIENCES INC COM COGT COGT 1,035,528 $7.4m2.46% 2.46% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.0m
16 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 469,949 $6.6m2.17% 2.17% ReducedShares held: Q3 2024 500.0k, Q4 2024 469.9k, Q1 2025 494.9k, Q2 2025 469.9k -25.0k -25,000 -5.0%
17 ARVINAS INC COM ARVN ARVN 850,000 $6.3m2.07% 2.07% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 229.9k, Q2 2025 850.0k +620.1k +620,100 269.7%
18 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 476,443 $6.2m2.04% 2.04% ReducedShares held: Q3 2024 0, Q4 2024 609.2k, Q1 2025 609.2k, Q2 2025 476.4k -132.8k -132,782 -21.8%
19 VIR BIOTECHNOLOGY INC COM VIR VIR 1,068,062 $5.4m1.78% 1.78% UnchangedShares held: Q3 2024 0, Q4 2024 897.9k, Q1 2025 1.1m, Q2 2025 1.1m
20 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 209,649 $4.5m1.51% 1.51% ReducedShares held: Q3 2024 417.9k, Q4 2024 349.6k, Q1 2025 249.6k, Q2 2025 209.6k -40.0k -40,000 -16.0%
21 DELCATH SYS INC COM NEW DCTH DCTH 322,390 $4.4m1.45% 1.45% AddedShares held: Q3 2024 100.4k, Q4 2024 100.4k, Q1 2025 100.4k, Q2 2025 322.4k +222.0k +222,025 221.2%
22 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 40,000 $4.2m1.40% 1.40% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 40.0k
23 CG ONCOLOGY INC COM CGON CGON 155,000 $4.0m1.33% 1.33% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 155.0k
24 NEURONETICS INC COM STIM STIM 1,099,700 $3.8m1.27% 1.27% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.1m, Q2 2025 1.1m -300 -300 -0.0%
25 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 183,085 $3.8m1.26% 1.26% ReducedShares held: Q3 2024 115.2k, Q4 2024 284.1k, Q1 2025 264.1k, Q2 2025 183.1k -81.0k -81,000 -30.7%
26 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 206,800 $3.7m1.24% 1.24% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 206.8k
27 DYNE THERAPEUTICS INC COM DYN DYN 363,837 $3.5m1.15% 1.15% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 358.8k, Q2 2025 363.8k +5.0k +5,000 1.4%
28 TECTONIC THERAPEUTIC INC COM TECX TECX 163,696 $3.3m1.08% 1.08% ReducedShares held: Q3 2024 267.1k, Q4 2024 142.3k, Q1 2025 269.1k, Q2 2025 163.7k -105.4k -105,394 -39.2%
29 MAZE THERAPEUTICS INC COM MAZE MAZE 262,740 $3.2m1.07% 1.07% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 322.7k, Q2 2025 262.7k -60.0k -60,000 -18.6%
30 JANUX THERAPEUTICS INC COM JANX JANX 129,691 $3.0m0.99% 0.99% UnchangedShares held: Q3 2024 0, Q4 2024 74.7k, Q1 2025 129.7k, Q2 2025 129.7k
31 FULCRUM THERAPEUTICS INC COM FULC FULC 428,521 $2.9m0.98% 0.98% AddedShares held: Q3 2024 75.0k, Q4 2024 200.1k, Q1 2025 200.1k, Q2 2025 428.5k +228.4k +228,425 114.2%
32 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 1,000,221 $2.7m0.90% 0.90% ReducedShares held: Q3 2024 0, Q4 2024 1.1m, Q1 2025 1.0m, Q2 2025 1.0m -25.0k -25,000 -2.4%
33 BIOGEN INC COM BIIB BIIB 21,516 $2.7m0.89% 0.89% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 21.5k
34 VIKING THERAPEUTICS INC COM VKTX VKTX 100,000 $2.7m0.88% 0.88% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 50.0k, Q2 2025 100.0k +50.0k +50,000 100.0%
35 RELAY THERAPEUTICS INC COM RLAY RLAY 743,308 $2.6m0.85% 0.85% UnchangedShares held: Q3 2024 693.4k, Q4 2024 693.3k, Q1 2025 743.3k, Q2 2025 743.3k
36 ARCTURUS THERAPEUTICS HLDGS COM ARCT ARCT 175,000 $2.3m0.75% 0.75% UnchangedShares held: Q3 2024 0, Q4 2024 200.0k, Q1 2025 175.0k, Q2 2025 175.0k
37 GERON CORP COM GERN GERN 1,600,000 $2.3m0.75% 0.75% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 150.0k, Q2 2025 1.6m +1.4m +1,450,000 966.7%
38 KALVISTA PHARMACEUTICALS INC COM KALV KALV 198,528 $2.2m0.74% 0.74% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 198.5k
39 KODIAK SCIENCES INC COM KOD KOD 599,534 $2.2m0.74% 0.74% ReducedShares held: Q3 2024 476.6k, Q4 2024 576.2k, Q1 2025 649.5k, Q2 2025 599.5k -50.0k -50,000 -7.7%
40 LEXEO THERAPEUTICS INC COM LXEO LXEO 550,029 $2.2m0.73% 0.73% UnchangedShares held: Q3 2024 257.2k, Q4 2024 499.3k, Q1 2025 550.0k, Q2 2025 550.0k
41 METSERA INC COM COM 77,316 $2.2m0.73% 0.73% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 150.0k, Q2 2025 77.3k -72.7k -72,684 -48.5%
42 VENTYX BIOSCIENCES INC COM VTYX VTYX 967,590 $2.1m0.69% 0.69% ReducedShares held: Q3 2024 192.6k, Q4 2024 1.1m, Q1 2025 1.2m, Q2 2025 967.6k -250.0k -250,000 -20.5%
43 CUMBERLAND PHARMACEUTICALS I COM CPIX CPIX 595,932 $2.0m0.66% 0.66% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 740.0k, Q2 2025 595.9k -144.1k -144,068 -19.5%
44 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 868,069 $1.8m0.59% 0.59% NewShares held: Q3 2024 483.6k, Q4 2024 0, Q1 2025 0, Q2 2025 868.1k
45 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 49,179 $1.7m0.58% 0.58% ReducedShares held: Q3 2024 0, Q4 2024 357.2k, Q1 2025 244.2k, Q2 2025 49.2k -195.0k -195,000 -79.9%
46 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 65,431 $1.7m0.57% 0.57% UnchangedShares held: Q3 2024 0, Q4 2024 152.2k, Q1 2025 65.4k, Q2 2025 65.4k
47 UNIQURE NV SHS QURE QURE 119,986 $1.7m0.55% 0.55% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 120.0k
48 SILENCE THERAPEUTICS PLC ADS SLN SLN 873,568 $1.4m0.46% 0.46% NewShares held: Q3 2024 587.3k, Q4 2024 0, Q1 2025 0, Q2 2025 873.6k
49 ARCUS BIOSCIENCES INC COM RCUS RCUS 163,363 $1.3m0.44% 0.44% UnchangedShares held: Q3 2024 744.0k, Q4 2024 378.4k, Q1 2025 163.4k, Q2 2025 163.4k
50 APELLIS PHARMACEUTICALS INC COM APLS APLS 75,000 $1.3m0.43% 0.43% UnchangedShares held: Q3 2024 0, Q4 2024 3.6k, Q1 2025 75.0k, Q2 2025 75.0k
51 ALECTOR INC COM ALEC ALEC 900,000 $1.3m0.42% 0.42% ReducedShares held: Q3 2024 0, Q4 2024 950.0k, Q1 2025 950.0k, Q2 2025 900.0k -50.0k -50,000 -5.3%
52 NUVATION BIO INC COM CL A NUVB NUVB 619,258 $1.2m0.40% 0.40% UnchangedShares held: Q3 2024 83.3k, Q4 2024 83.4k, Q1 2025 619.3k, Q2 2025 619.3k
53 VISTAGEN THERAPEUTICS INC COM VTGN VTGN 601,703 $1.2m0.40% 0.40% UnchangedShares held: Q3 2024 0, Q4 2024 77.6k, Q1 2025 601.7k, Q2 2025 601.7k
54 CYBIN INC COM NEW COM NEW 140,475 $1.2m0.39% 0.39% ReducedShares held: Q3 2024 367.2k, Q4 2024 397.2k, Q1 2025 397.2k, Q2 2025 140.5k -256.7k -256,700 -64.6%
55 TOURMALINE BIO INC COM TRML TRML 67,927 $1.1m0.36% 0.36% UnchangedShares held: Q3 2024 108.5k, Q4 2024 67.9k, Q1 2025 67.9k, Q2 2025 67.9k
56 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 161,137 $1.0m0.35% 0.35% NewShares held: Q3 2024 544.3k, Q4 2024 0, Q1 2025 0, Q2 2025 161.1k
57 VERU INC COM COM 1,425,239 $829.2k0.27% 0.27% UnchangedShares held: Q3 2024 946.4k, Q4 2024 945.2k, Q1 2025 1.4m, Q2 2025 1.4m
58 ORUKA THERAPEUTICS INC COM ORKA ORKA 68,574 $768.7k0.25% 0.25% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 175.0k, Q2 2025 68.6k -106.4k -106,426 -60.8%
59 ISHARES TR ISHARES BIOTECH IBB IBB 5,755 $728.1k0.24% 0.24% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.8k
60 SANGAMO THERAPEUTICS INC COM SGMOQ SGMOQ 1,260,179 $682.1k0.23% 0.23% ReducedShares held: Q3 2024 0, Q4 2024 1.9m, Q1 2025 1.9m, Q2 2025 1.3m -600.0k -600,000 -32.2%
61 IMMUNIC INC COM COM 914,170 $637.6k0.21% 0.21% UnchangedShares held: Q3 2024 493.5k, Q4 2024 1.6m, Q1 2025 914.2k, Q2 2025 914.2k
62 INHIBRX BIOSCIENCES INC COM INBX INBX 42,122 $601.1k0.20% 0.20% UnchangedShares held: Q3 2024 42.1k, Q4 2024 42.1k, Q1 2025 42.1k, Q2 2025 42.1k
63 INFLARX NV COM IFRX IFRX 705,010 $557.0k0.18% 0.18% NewShares held: Q3 2024 705.0k, Q4 2024 0, Q1 2025 0, Q2 2025 705.0k
64 KEZAR LIFE SCIENCES INC COM NEW KZR KZR 106,901 $489.6k0.16% 0.16% UnchangedShares held: Q3 2024 0, Q4 2024 106.9k, Q1 2025 106.9k, Q2 2025 106.9k
65 VYNE THERAPEUTICS INC COM COM 290,000 $478.5k0.16% 0.16% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 290.0k
66 IBIO INC COM NEW IBIO IBIO 599,913 $457.8k0.15% 0.15% UnchangedShares held: Q3 2024 600.0k, Q4 2024 599.9k, Q1 2025 599.9k, Q2 2025 599.9k
67 MIND MEDICINE MINDMED INC COM NEW COM NEW 62,691 $406.9k0.13% 0.13% UnchangedShares held: Q3 2024 62.5k, Q4 2024 62.7k, Q1 2025 62.7k, Q2 2025 62.7k
68 BIOMX INC COM NEW COM NEW 892,976 $401.8k0.13% 0.13% UnchangedShares held: Q3 2024 893.0k, Q4 2024 893.0k, Q1 2025 893.0k, Q2 2025 893.0k
69 LYELL IMMUNOPHARMA INC COM NEW LYEL LYEL 43,799 $387.2k0.13% 0.13% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 43.8k
70 NYXOAH S A SHS NYXH NYXH 50,627 $378.7k0.13% 0.13% NewShares held: Q3 2024 50.7k, Q4 2024 0, Q1 2025 0, Q2 2025 50.6k
71 ANAPTYSBIO INC COM ANAB ANAB 15,662 $347.7k0.12% 0.12% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 15.7k
72 VERA THERAPEUTICS INC CL A VERA VERA 14,096 $332.1k0.11% 0.11% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 14.1k
73 ZYMEWORKS INC COM ZYME ZYME 25,000 $313.8k0.10% 0.10% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 25.0k
74 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 265,769 $308.3k0.10% 0.10% UnchangedShares held: Q3 2024 266.4k, Q4 2024 265.8k, Q1 2025 265.8k, Q2 2025 265.8k
75 IMMATICS N.V SHS IMTX IMTX 49,396 $265.8k0.09% 0.09% NewShares held: Q3 2024 49.4k, Q4 2024 0, Q1 2025 0, Q2 2025 49.4k
76 VIGIL NEUROSCIENCE INC COM VIGL VIGL 31,360 $249.3k0.08% 0.08% ReducedShares held: Q3 2024 0, Q4 2024 500.0k, Q1 2025 250.0k, Q2 2025 31.4k -218.6k -218,640 -87.5%
77 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 213,052 $247.1k0.08% 0.08% UnchangedShares held: Q3 2024 213.4k, Q4 2024 213.1k, Q1 2025 213.1k, Q2 2025 213.1k
78 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 110,000 $242.0k0.08% 0.08% ReducedShares held: Q3 2024 0, Q4 2024 350.0k, Q1 2025 175.0k, Q2 2025 110.0k -65.0k -65,000 -37.1%
79 CARTESIAN THERAPEUTICS INC COM NEW RNAC RNAC 22,166 $230.3k0.08% 0.08% UnchangedShares held: Q3 2024 52.2k, Q4 2024 52.2k, Q1 2025 22.2k, Q2 2025 22.2k
80 ANEBULO PHARMACEUTICALS INC COM ANEB ANEB 157,720 $227.1k0.08% 0.08% UnchangedShares held: Q3 2024 157.9k, Q4 2024 157.7k, Q1 2025 157.7k, Q2 2025 157.7k
81 TERNS PHARMACEUTICALS INC COM COM 58,491 $218.2k0.07% 0.07% ReducedShares held: Q3 2024 308.5k, Q4 2024 308.5k, Q1 2025 308.5k, Q2 2025 58.5k -250.0k -250,000 -81.0%
82 EVAXION AS SPONSORED ADS EVAX EVAX 80,000 $196.0k0.06% 0.06% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 80.0k, Q2 2025 80.0k
83 FAETH THERAPEUTICS INC COM NEW FTH FTH 22,497 $193.0k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 22.5k
84 LYRA THERAPEUTICS INC COM NEW LYRA LYRA 21,161 $189.6k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 21.2k
85 AETHLON MED INC COM NEW COM NEW 153,659 $184.4k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 153.7k
86 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 35,300 $176.1k0.06% 0.06% ReducedShares held: Q3 2024 970.4k, Q4 2024 970.3k, Q1 2025 200.0k, Q2 2025 35.3k -164.7k -164,700 -82.3%
87 VOYAGER THERAPEUTICS INC COM VYGR VYGR 55,766 $173.4k0.06% 0.06% UnchangedShares held: Q3 2024 55.9k, Q4 2024 55.8k, Q1 2025 55.8k, Q2 2025 55.8k
88 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 176,479 $166.9k0.06% 0.06% ReducedShares held: Q3 2024 0, Q4 2024 1.6m, Q1 2025 1.4m, Q2 2025 176.5k -1.2m -1,241,473 -87.5%
89 PEPGEN INC COM PEPG PEPG 150,000 $166.5k0.06% 0.06% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 150.0k, Q2 2025 150.0k
90 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 25,107 $139.3k0.05% 0.05% UnchangedShares held: Q3 2024 55.2k, Q4 2024 55.1k, Q1 2025 25.1k, Q2 2025 25.1k
91 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 27,257 $117.5k0.04% 0.04% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 27.3k, Q2 2025 27.3k
92 MACROGENICS INC COM MGNX MGNX 80,071 $96.9k0.03% 0.03% UnchangedShares held: Q3 2024 80.1k, Q4 2024 80.1k, Q1 2025 80.1k, Q2 2025 80.1k
93 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 11,984 $91.3k0.03% 0.03% UnchangedShares held: Q3 2024 387.6k, Q4 2024 12.0k, Q1 2025 12.0k, Q2 2025 12.0k
94 AIRSCULPT TECHNOLOGIES INC COM AIRS AIRS 17,951 $86.7k0.03% 0.03% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 18.0k
95 SPRUCE BIOSCIENCES INC COM COM 1,000,000 $72.5k0.02% 0.02% UnchangedShares held: Q3 2024 0, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
96 ALPHA TEKNOVA INC COM TKNO TKNO 14,008 $68.8k0.02% 0.02% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 14.0k, Q2 2025 14.0k
97 HOOKIPA PHARMA INC COM NEW COM NEW 52,996 $66.5k0.02% 0.02% UnchangedShares held: Q3 2024 53.1k, Q4 2024 53.0k, Q1 2025 53.0k, Q2 2025 53.0k
98 THERIVA BIOLOGICS INC COM NEW TOVX TOVX 120,031 $52.1k0.02% 0.02% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 120.0k, Q2 2025 120.0k
99 TRAWS PHARMA INC COM NEW TRAW TRAW 28,493 $42.2k0.01% 0.01% UnchangedShares held: Q3 2024 0, Q4 2024 98.5k, Q1 2025 28.5k, Q2 2025 28.5k
100 AUTONOMIX MED INC COM NEW COM NEW 20,000 $31.4k0.01% 0.01% UnchangedShares held: Q3 2024 0, Q4 2024 20.0k, Q1 2025 20.0k, Q2 2025 20.0k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
SPDR S&P 500 ETF TR SPY SPY 25,000 $14.0m25.0k shares
BLUEPRINT MEDICINES CORP BPMC BPMC 113,904 $10.1m113.9k shares
ULTRAGENYX PHARMACEUTICAL IN RARE RARE 216,989 $7.9m217.0k shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 280,000 $6.2m280.0k shares
ENLIVEN THERAPEUTICS INC ELVN ELVN 289,538 $5.7m289.5k shares
TREVI THERAPEUTICS INC TRVI TRVI 575,000 $3.6m575.0k shares
BRIDGEBIO PHARMA INC BBIO BBIO 90,837 $3.1m90.8k shares
KEROS THERAPEUTICS INC KROS KROS 274,009 $2.8m274.0k shares
ABEONA THERAPEUTICS INC ABEO ABEO 533,581 $2.5m533.6k shares
EVOLUS INC EOLS EOLS 193,265 $2.3m193.3k shares
VERVE THERAPEUTICS INC 358,393 $1.6m358.4k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 221,911 $1.5m221.9k shares
TELADOC HEALTH INC TDOC TDOC 150,000 $1.2m150.0k shares
ONKURE THERAPEUTICS INC OKUR OKUR 253,754 $1.1m253.8k shares
NEKTAR THERAPEUTICS 1,579,528 $1.1m1.6m shares
SOLID BIOSCIENCES INC SLDB SLDB 230,000 $851.0k230.0k shares
89BIO INC ETNB ETNB 100,000 $727.0k100.0k shares
OLEMA PHARMACEUTICALS INC OLMA OLMA 191,994 $721.9k192.0k shares
MONTE ROSA THERAPEUTICS INC GLUE GLUE 136,575 $633.7k136.6k shares
CHANNEL THERAPEUTICS CORPORA 440,849 $626.0k440.8k shares
PYXIS ONCOLOGY INC PYXS PYXS 613,253 $600.9k613.3k shares
SPRINGWORKS THERAPEUTICS INC SWTX SWTX 12,519 $552.5k12.5k shares
LYELL IMMUNOPHARMA INC 43,802 $471.3k43.8k shares
ITEOS THERAPEUTICS INC ITOS ITOS 78,585 $469.2k78.6k shares
AETHLON MED INC 1,229,285 $440.1k1.2m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
CIDARA THERAPEUTICS INC CDTX · Put CDTXPut 501,600 $24.4m501.6k shares New
ULTRAGENYX PHARMACEUTICAL IN RARE · Call RARECall 563,100 $20.5m563.1k shares Added
SOLENO THERAPEUTICS INC SLNO · Call SLNOCall 200,000 $16.8m200.0k shares Reduced
SOLENO THERAPEUTICS INC SLNO · Put SLNOPut 200,000 $16.8m200.0k shares Added
CIDARA THERAPEUTICS INC CDTX · Call CDTXCall 321,000 $15.6m321.0k shares New
CAPRICOR THERAPEUTICS INC CAPR · Put CAPRPut 1,360,200 $13.5m1.4m shares New
UNIQURE NV QURE · Call QURECall 800,000 $11.2m800.0k shares Added
ULTRAGENYX PHARMACEUTICAL IN RARE · Put RAREPut 300,000 $10.9m300.0k shares Added
PRAXIS PRECISION MEDICINES I PRAX · Call PRAXCall 242,400 $10.2m242.4k shares New
VIKING THERAPEUTICS INC VKTX · Call VKTXCall 350,000 $9.3m350.0k shares Added
MOONLAKE IMMUNOTHERAPEUTICS MLTX · Put MLTXPut 194,500 $9.2m194.5k shares Added
CAPRICOR THERAPEUTICS INC CAPR · Call CAPRCall 700,000 $7.0m700.0k shares Added
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 332,100 $5.7m332.1k shares New
CYTOKINETICS INC CYTK · Call CYTKCall 150,000 $5.0m150.0k shares New
KALVISTA PHARMACEUTICALS INC KALV · Call KALVCall 400,000 $4.5m400.0k shares New
MOONLAKE IMMUNOTHERAPEUTICS MLTX · Call MLTXCall 94,500 $4.5m94.5k shares Unchanged
BIOHAVEN LTD BHVN · Call BHVNCall 300,000 $4.2m300.0k shares Reduced
FULCRUM THERAPEUTICS INC FULC · Call FULCCall 534,000 $3.7m534.0k shares New
VERA THERAPEUTICS INC VERA · Call VERACall 153,200 $3.6m153.2k shares New
SCHOLAR ROCK HLDG CORP SRRK · Call SRRKCall 100,000 $3.5m100.0k shares Unchanged
APOGEE THERAPEUTICS INC Put Put 79,100 $3.4m79.1k shares Added
TEVA PHARMACEUTICAL INDS LTD Call Call 200,000 $3.4m200.0k shares Unchanged
ALTIMMUNE INC ALT · Call ALTCall 827,500 $3.2m827.5k shares New
CENTESSA PHARMACEUTICALS PLC Call Call 200,000 $2.6m200.0k shares New
AKERO THERAPEUTICS INC AKRO · Call AKROCall 44,400 $2.4m44.4k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15